Boussard & Gavaudan Investment Management’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$1.97K	–	150
2022 Q3	$1.97K	Hold	200,000	–	–	0.28%	74
2022 Q2	$1.96K	Hold	200,000	–	–	0.36%	62
2022 Q1	$1.96K	Hold	200,000	–	–	0.26%	43
2021 Q4	$1.95M	Hold	200,000	–	–	0.17%	81
2021 Q3	$1.94K	Hold	200,000	–	–	0.16%	76
2021 Q2	$1.94M	Buy	+200,000	New	+$1.96M	0.18%	43

Boussard & Gavaudan Investment Management's SSAA Position: Q4 2022 in Review

Boussard & Gavaudan Investment Management sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 200,000 shares — an estimated $1.97K sold.

Boussard & Gavaudan Investment Management first reported a position in SSAA in Q2 2021 and held it in 6 quarters. The position peaked at $1.95M in Q4 2021. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Boussard & Gavaudan Investment Management reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 200,000 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $1.97K.
Boussard & Gavaudan Investment Management first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 6 quarters.
Boussard & Gavaudan Investment Management's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $1.95M in Q4 2021.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.